The prion folding problem.

P M Harrison; P Bamborough; V Daggett; S B Prusiner; F E Cohen

doi:10.1016/s0959-440x(97)80007-3

Home/Archive/PubMed

PubMed · 9032055

The prion folding problem.

P M Harrison·P Bamborough·V Daggett·S B Prusiner·F E Cohen

View original source ↗Export metadata ↓

Abstract

Prion diseases are neurodegenerative disorders in which dramatic conformational change in the structure of the prion protein is the fundamental event. This structural transition involves the loss of substantial alpha-helical content and the acquisition of beta-sheet structure. A convergence of recent biological and structural studies argues that the mechanism underlying the prion diseases is truly unprecedented.

Explore related subjects

Biopolymers Magnetic Resonance Spectroscopy Prions Protein Folding Protein Structure, Tertiary Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

P M Harrison, P Bamborough, V Daggett, S B Prusiner, F E Cohen. 1997. The prion folding problem.. https://doi.org/10.1016/s0959-440x(97)80007-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Toroid formation in charge neutralized flexible or semi-flexible biopolymers: potential pathway for assembly of DNA carriers.

BACKGROUND: The theoretical state diagram for semi-flexible macromolecules such as DNA predicts that a tightly wound toroid can be a stable structure. Experimentally, toroids roughly 100 nm in diameter are routinely observed for DNA in the presence of multivalent cations at low DNA concentration. Theory also predicts toroids can form between non-DNA semi-flexible polymers and multivalent counterions. This phenomenon provides a means to co-package DNA with functionalized anionic polymers to create gene delivery systems. METHODS AND RESULTS: We show using electron microscopy that non-DNA polymers (polylysine, polyglutamic acid, and dextran sulfate) form toroids when mixed with multi- or polyvalent ions of opposite charge. The non-DNA toroids are similar in diameter to ones made with DNA. The results using dextran sulfate, a semi-flexible polymer, are explained by current theory. However, theory predicts that high flexibility in polypeptides should discourage their incorporation into stable toroids. To explain these latter observations we propose that charge neutralization facilitates secondary structure formation, which confers stiffness, thereby allowing stable toroids for the polypeptides studied. We measured the secondary structure of the toroid-forming polypeptides using circular dichroism (CD). The CD spectrum indicates the polypeptides undergo transitions from non-ordered structures (random coil) to ordered secondary structures (either alpha-helix or beta-sheet) upon charge neutralization which supports the hypothesis. The type of secondary structure is dependent on the type of multivalent counterion used to form the toroids. Formation of the polypeptide toroids confers resistance to heat denaturation of the resulting polypeptide secondary structure. The CD spectrum of DNA in a toroid also is changed from that of uncomplexed DNA, but all of the counterions used to form DNA toroids created structures with similar CD spectra in the DNA region (250-290 nm). CONCLUSIONS: The toroid structure obtained using DNA is observed in other semi-flexible non-DNA polymers such as dextran sulfate, and also in flexible polymers such as polylysine and polyglutamic acid upon charge neutralization with multivalent counterions. In the flexible polymers we propose that this phenomenon is due to induction of secondary structure upon charge neutralization, which decreases polymer flexibility, i.e. increases polymer stiffness, to enable toroid formation. These results have significant implications for the co-assembly of non-DNA anionic polymers with DNA to create nanoscopic gene carriers.

Biopolymers↗

PubMed2004

Crystallization of oxytetracycline from fermentation waste liquor: influence of biopolymer impurities.

Organic impurities in the fermentation broth of antibiotic production impose great difficulties in the crystallization and recovery of antibiotics from the concentrated waste liquor. In the present laboratory study, the inhibitory effect of biopolymers on antibiotic crystallization was investigated using oxytetracycline (OTC) as the model antibiotic. Organic impurities separated from actual OTC fermentation waste liquor by ultrafiltration were dosed into a pure OTC solution at various concentrations. The results demonstrated that small organic molecules with an apparent molecular weight (AMW) of below 10,000 Da did not affect OTC crystallization significantly. However, large biopolymers, especially polysaccharides, in the fermentation waste caused severe retardation of crystal growth and considerable deterioration in the purity of the OTC crystallized. Atomic force microscopy (AFM) revealed that OTC nuclei formed in the solution attached to the surfaces of large organic molecules, probably polysaccharides, instead of being surrounded by proteins as previously thought. It is proposed that the attachment of OTC nuclei to biopolymers would prevent OTC from rapid crystallization, resulting in a high OTC residue in the aqueous phase. In addition, the adsorption of OTC clusters onto biopolymers would destabilize the colloidal system of organic macromolecules and promote particle flocculation. OTC crystallization would therefore take place with the precipitation of abundant organic impurities. Hence, the removal of polysaccharides and other biopolymers by ultrafiltration can be an effective means of improving the recovery of OTC and similar antibiotics by crystallization from the fermentation waste.

Biopolymers↗

PubMed2004

Synthesis of low-shrinkage polymerizable liquid-crystal monomers.

Polymerization shrinkage remains a major barrier to the universal use of resin restorative in large posterior cavity preparations. A new bifunctional liquid crystal (LC) monomer, 2-(t-butyl), 1,4-bis-[4-(6-acryloxy-hexane-1-oxy)-benzoyloxy] benzene, with exceptionally low polymerization shrinkage, has recently been discovered. The purpose of this communication is to report a new, easy, high-yield synthetic route to synthesize this compound in comfortable larger batches. Synthetic and isolation details, chemical characteristics, and the polymerizable properties of a new structurally related by-product monomer, namely, 2-(t-butyl),1-[4-(6-acryloxy-hexane-1-oxy)-benzoyloxy], 4-[4-[6-(3-acryl oxy-propionoxy)-hexane-1-oxy]-benzoyloxy]-benzene, is also reported. The structural confirmation of this by-product indicates that it resulted from the Michael-type addition of acrylate ion on one of the terminal acryloxy groups of 2-(t-butyl), 1,4-bis-[4-(6-acryloxy-hexane-1-oxy)-benzoyloxy] benzene. The by-product itself, as well as the natural blend of the aforesaid both products as formed in the reaction mixture, also polymerized at room temperature with lesser volume shrinkage as compared to the conventional control (GTE) at similar degrees of conversion.

Biopolymers↗